AK

Ajeet Kumar Giri

Active Director Director DIN 07919506
DIN 07919506 First appointment Sep 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Ajeet Kumar Giri

Data last updated:

Ajeet Kumar Giri is a Director at Kokia Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Kokia Pharmaceuticals Private Limited reported revenue of ₹90,525 (FY 2020).

DIN 07919506
Primary Designation Director
Industry Trading
First Appointment 19 Sep 2017
Oldest Company Age 9 yrs
Largest company Kokia Pharmaceuticals Private Limited · ₹90,525 (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Sep 20172017₹90,525 (FY 2020)Active

Board colleagues of Ajeet Kumar Giri

NameDINCompanyDesignation
Neetu Giri07919523Kokia Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kokia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ajeet Kumar Giri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajeet Kumar Giri

Ajeet Kumar Giri currently holds 1 directorship: Kokia Pharmaceuticals Private Limited (Director, since 19 Sep 2017, revenue ₹90,525 (FY 2020)).

Ajeet Kumar Giri was first appointed on 19 Sep 2017 as Director at Kokia Pharmaceuticals Private Limited.

The current boards of Ajeet Kumar Giri's companies include Neetu Giri (Kokia Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available